Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin on Trauma-Associated Memories
NCT03875391Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Mar 2019
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
Randomised, double-blind trial of oxytocin nasal spray in post-traumatic stress disorder (PTSD) (2 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Change of Intrusive Memories at 4 days. Started Mar 2019; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT03875391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03875391.